Mimin Liu

Mimin Liu

Auto-generated profile, based on publicly available information

Mimin Liu

Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
HJHailun Jiang
Hailun Jiang
Ghulam M. AshrafGhulam M. Ashraf
Ghulam M. Ashraf
MLMimin Liu
Mimin Liu
KZKaiyue Zhao
Kaiyue Zhao
YWYu Wang
Yu Wang
RLRui Liu
Rui Liu
Vascular dementia (VaD) is a common cause of cognitive decline and dementia of vascular origin, but the precise pathological mechanisms are unknown, and so effective clinical treatments have not been established. Tilianin, the principal active compound of total flavonoid extract from Dracocephalum moldavica L., is a candidate therapy for cardio‐cerebrovascular diseases in China. However, its potential in the treatment of VaD is unclear. The present study is aimed at investigating the protective effects of tilianin on VaD and exploring the underlying mechanism of the action. A model of VaD was established by permanent 2‐vessel occlusion (2VO) in rats. Human neurons (hNCs) differentiated from human‐induced pluripotent stem cells were used to establish an oxygen‐glucose deprivation (OGD) model. The therapeutic effects and potential mechanisms of tilianin were identified using behavioral tests, histochemistry, and multiple molecular biology techniques such as Western blot analysis and gene silencing. The results demonstrated that tilianin modified spatial cognitive impairment, neurodegeneration, oxidation, and apoptosis in rats with VaD and protected hNCs against OGD by increasing cell viability and decreasing apoptosis rates. A study of the mechanism indicated that tilianin restored p‐CaMKII/ERK1/2/CREB signaling in the hippocampus, maintaining hippocampus‐independent memory. In addition, tilianin inhibited an ox‐CaMKII/p38 MAPK/JNK/NF‐κB associated inflammatory response caused by cerebral oxidative stress imbalance in rats with VaD. Furthermore, specific CaMKIIα siRNA action revealed that tilianin‐exerted neuroprotection involved increase of neuronal viability, inhibition of apoptosis, and suppression of inflammation, which was dependent on CaMKIIα. In conclusion, the results suggested the neuroprotective effect of tilianin in VaD and the potential mechanism associated with dysfunction in the regulation of p‐CaMKII‐mediated long‐term memory and oxidation and inflammation involved with ox‐CaMKII, which may lay the foundation for clinical trials of tilianin for the treatment of VaD in the future.

Verified
Journal Article
Open access
PDF file
ZCZhongdi Cai
Zhongdi Cai
KZKaiyue Zhao
Kaiyue Zhao
LZLi Zeng
Li Zeng
MLMimin Liu
Mimin Liu
TSTing Sun
Ting Sun
RLRui Liu
Rui Liu
Alzheimer’s disease (AD) is a common neurodegenerative disorder characterized by cognitive dysfunction. The role of long non-coding RNAs (lncRNAs) with the action of competitive endogenous RNA (ceRNA) in AD remains unclear. The present study aimed to identify significantly differentially expressed lncRNAs (SDELs) and establish lncRNA-associated ceRNA networks via RNA sequencing analysis and a quantitative real-time Polymerase Chain Reaction (qPCR) assay using transgenic mice with five familial AD mutations. A total of 53 SDELs in the cortex and 51 SDELs in the hippocampus were identified, including seven core SDELs common to both regions. The functions and pathways were then investigated through the potential target genes of SDELs via Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses, which indicate biological effects, action distributions, and pathological transductions associated with AD. Based on the ceRNA hypothesis, integrated ceRNA networks in the cortex and hippocampus of lncRNA-miRNA-mRNA were constructed. The core SDEL-mediated ceRNA relationship was established and the expression of these RNAs was verified by qPCR. The results identified lncRNA ENSMUST00000127786 and highlighted miRNAs and mRNAs as potential key mediators in AD. These findings provide AD-derived lncRNA-mediated ceRNA profiles, and further experimental evidence is needed to confirm these identified ceRNA regulatory relationships.

1 January 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
ZCZhongdi Cai
Zhongdi Cai
MLMimin Liu
Mimin Liu
FYFengjuan Yuan
Fengjuan Yuan
LZLi Zeng
Li Zeng
KZKaiyue Zhao
Kaiyue Zhao
RLRui Liu
Rui Liu
Hyssopus cuspidatus Boriss (H. cuspidatus) is a traditional Chinese medicine commonly used in the treatment of asthma. In the present study, we applied bioinformatics techniques for mRNA‐miRNA profiling to elucidate the potential mechanisms of H. cuspidatus in asthma treatment. Bioactive compounds from H. cuspidatus, potential therapeutic targets of H. cuspidatus, and asthma‐related targets were identified from the literature and databases. The intersection of H. cuspidatus‐related targets and asthma‐related targets was identified using the STRING platform. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses were performed using the Metascape platform. Networks were constructed from these nodes using Cytoscape. The results showed that 23 active compounds were identified in H. cuspidatus, sharing 122 common asthma‐related targets. Moreover, 43 miRNAs regulating 19 key targets involved in the antiasthmatic effects of H. cuspidatus were identified. Further analysis of biological pathways, active compound‐key target‐pathway network, and active compound‐key target‐miRNA network indicated that the antiasthmatic effects of H. cuspidatus mainly occurred through caffeic acid, methyl rosmarinate, luteolin, esculetin, and 8‐hydroxycirsimaritin. These compounds interacted with multiple miRNAs, including miR‐99a, miR‐498, miR‐33b, and miR‐18a, regulating multiple genes, including JAK, STAT3, EGFR, LYN, and IL‐6, in multiple pathways, including those involved in the regulation of JAK‐STAT signaling, EGFR tyrosine kinase inhibitor resistance, PI3K‐Akt signaling, and inflammation. In summary, we have elucidated the potential mechanisms of H. cuspidatus treatment of asthma from a systemic and holistic perspective through analysis of compound‐mRNA‐miRNA interaction. Our study should provide new insights for further research on H. cuspidatus treatment of asthma.